Company intelligence / Profile preview

Legend Capital

Beijing, Beijing Municipality, Chinalegendcapital.com.cn ↗

Ownership: Private
Development stage: Other

Overview

Legend Capital is a leading Chinese venture capital and private equity firm established in 2001. It manages over $10 billion in assets and invests across early-stage and growth-stage opportunities, with a strong focus on technology, healthcare, pharmaceuticals, biotech, and related sectors. The firm has invested in around 600 companies globally—including notable life science firms such as Recbio (vaccines), Pharmaron (CRO), BioNano Genomics (genomic mapping), Nuwacell Biotechnologies (iPSC)—and provides comprehensive support to its portfolio through governance, strategy guidance, R&D resources, and financial backing.

Industry: Investors

Partnerships

Founders FundFormation8GGV CapitalWishBioNano GenomicsAxonics Modulation TechnologiesNuwacell Biotechnologies

Beyond the preview

Go deeper on Legend Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Legend Capital.

Explore the full profile